The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Analysis of Structural Requirements for the Absorption of Drugs and Macromolecules from the Nasal Cavity
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
FRACTURE FACES OF ZONULAE OCCLUDENTES FROM "TIGHT" AND "LEAKY" EPITHELIA
Claude, P., & Goodenough, D. A. (1973) · The Journal of Cell Biology · doi:10.1083/jcb.58.2.390 · Cited by 1,096
Nasal absorption of insulin: enhancement by hydrophobic bile salts.
Gordon, G. S., Moses, A. C., Silver, R. D., Flier, J. S., & Carey, M. C. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.21.7419 · Cited by 278
Intranasal drug delivery by spray and drops
Hardy, J. G., Lee, S. W., & Wilson, C. G. (1985) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1985.tb05069.x · Cited by 250
Absorption of drugs from the nasal mucosa of rat
Shinichiro, H., Takatsuka, Y., Tai, M., & Hiroyuki, M. (1981) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(81)90058-2 · Cited by 249
Mechanisms for the enhancement of the nasal absorption of insulin by surfactants
Shinichiro, H., Takatsuka, Y., & Hiroyuki, M. (1981) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(81)90010-7 · Cited by 234
Intranasal Aerosolized Insulin: Mixed-Meal Studies and Long-Term Use in Type I Diabetes
Salzman, R., Manson, J. E., Griffing, G. T., Kimmerle, R., Ruderman, N., McCall, A., Stoltz, E. I., Mullin, C., Small, D., Armstrong, J., et al. (1985) · New England Journal of Medicine · doi:10.1056/nejm198504253121702 · Cited by 187
Bennett, H. P. J., Hudson, A. M., McMartin, C., & Purdon, G. E. (1977) · Biochemical Journal · doi:10.1042/bj1680009 · Cited by 177
Self-citationNasal absorption of propranolol from different dosage forms by rats and dogs
HUSSAIN, A. A., Hirai, S., & Bawarshi, R. (1980) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600691215 · Cited by 145
EFFECTS OF DDAVP, A SYNTHETIC ANALOGUE OF VASOPRESSIN, IN PATIENTS WITH CRANIAL DIABETES INSIPIDUS
Andersson, K., & ARNER, B. (1972) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1972.tb04772.x · Cited by 111
Distribution and removal of human serum albumin‐technetium 99m instilled intranasally.
Aoki, F. Y., & Crowley, J. (1976) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1976.tb00640.x · Cited by 90
Cited by
Nasal drug delivery—possibilities, problems and solutions
Illum, L. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00363-2 · Cited by 1,102
Basics and Recent Advances in Peptide and Protein Drug Delivery
Bruno, B. J., Miller, G. D., & Lim, C. S. (2013) · Therapeutic Delivery · doi:10.4155/tde.13.104 · Cited by 754
Nanoparticles for direct nose-to-brain delivery of drugs
Mistry, A., Stolnik, S., & Illum, L. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.06.019 · Cited by 734
Mechanism of intranasal drug delivery directly to the brain
Crowe, T. P., Greenlee, M. H. W., Kanthasamy, A. G., & Hsu, W. H. (2018) · Life Sciences · doi:10.1016/j.lfs.2017.12.025 · Cited by 721
Ahmed, T., & Aljaeid, B. (2016) · Drug Design, Development and Therapy · doi:10.2147/dddt.s99651 · Cited by 705
Intranasal Drug Delivery: How, Why and What For?
Pires, A., Fortuna, A., Alves, G., & Falcão, A. (2009) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.18433/j3nc79 · Cited by 641
Unlocking the promise of mRNA therapeutics
Rohner, E., Yang, R., Foo, K. S., Goedel, A., & Chien, K. R. (2022) · Nature Biotechnology · doi:10.1038/s41587-022-01491-z · Cited by 612
Intranasal delivery: Physicochemical and therapeutic aspects
Costantino, H. R., Illum, L., Brandt, G., Johnson, P. H., & Quay, S. C. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.03.025 · Cited by 598
Enhancement of Nasal Absorption of Insulin Using Chitosan Nanoparticles
Fernández-Urrusuno, R., Calvo, P., Remuñán-López, C., Vila-Jato, J. L., & José Alonso, M. (1999) · Pharmaceutical Research · doi:10.1023/a:1018908705446 · Cited by 587
Nasal mucociliary clearance as a factor in nasal drug delivery
Marttin, E., Schipper, N. G. M., Verhoef, J. C., & Merkus, F. W. H. M. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00059-8 · Cited by 469
Is nose-to-brain transport of drugs in man a reality?
Illum, L. (2004) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357022539 · Cited by 439
Nasal drug delivery: new developments and strategies
Illum, L. (2002) · Drug Discovery Today · doi:10.1016/s1359-6446(02)02529-1 · Cited by 431
Permeability issues in nasal drug delivery
Arora, P., Sharma, S., & Garg, S. (2002) · Drug Discovery Today · doi:10.1016/s1359-6446(02)02452-2 · Cited by 426
Penetration and enzymatic barriers to peptide and protein absorption
Lee, V. H. L., & Yamamoto, A. (1989) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(89)90018-5 · Cited by 413
Intranasal drug delivery: An efficient and non-invasive route for systemic administration
Grassin-Delyle, S., Buenestado, A., Naline, E., Faisy, C., Blouquit-Laye, S., Couderc, L.-J., Le Guen, M., Fischler, M., & Devillier, P. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.03.003 · Cited by 398
Therapeutic application of peptides and proteins: parenteral forever?
Antosova, Z., Mackova, M., Kral, V., & Macek, T. (2009) · Trends in Biotechnology · doi:10.1016/j.tibtech.2009.07.009 · Cited by 324
Effects of physicochemical properties and other factors on systemic nasal drug delivery
Behl, C. R., Pimplaskar, H. K., Sileno, A. P., deMeireles, J., & Romeo, V. D. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00063-x · Cited by 312
Nasal administration of opioids for pain management in adults
Dale, O., Hjortkjær, R., & Kharasch, E. D. (2002) · Acta Anaesthesiologica Scandinavica · doi:10.1034/j.1399-6576.2002.460702.x · Cited by 270
Minimizing systemic absorption of topically administered ophthalmic drugs
Urtti, A., & Salminen, L. (1993) · Survey of Ophthalmology · doi:10.1016/0039-6257(93)90141-s · Cited by 265
Intranasal administration of oxytocin: behavioral and clinical effects, a review
Veening, J. G., & Olivier, B. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.04.012 · Cited by 169
Nose-to-brain delivery of insulin enhanced by a nanogel carrier
Picone, P., Sabatino, M. A., Ditta, L. A., Amato, A., San Biagio, P. L., Mulè, F., Giacomazza, D., Dispenza, C., & Di Carlo, M. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.11.040 · Cited by 148
Clinical Pharmacokinetics of Intranasal Sumatriptan
Fuseau, E., Petricoul, O., Moore, K. H., Barrow, A., & Ibbotson, T. (2002) · Clinical Pharmacokinetics · doi:10.2165/00003088-200241110-00002 · Cited by 69
Quintana, D. S., Westlye, L. T., Smerud, K. T., Mahmoud, R. A., Andreassen, O. A., & Djupesland, P. G. (2018) · Hormones and Behavior · doi:10.1016/j.yhbeh.2018.05.004 · Cited by 52
McClure, R., Ong, H., Janve, V., Barton, S., Zhu, M., Li, B., Dawes, M., Jerome, W. G., Anderson, A., Massion, P., et al. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160289 · Cited by 54
Metadata
- Authors
- McMartin, C., Hutchinson, L. E. F., Hyde, R., & Peters, G. E.
- Venue
- Journal of Pharmaceutical Sciences
- Publisher
- Elsevier BV
- Published
- 1987-07
- Volume
- 76
- Issue
- 7
- Pages
- 535-540
- ISSN
- 0022-3549 (ISSN-L)
- OpenAlex
- W2047603891
- Cited by
- 349
- References
- 22
- FWCI
- 10.86
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.